View allArticlesCompany NewsCongressesPublications

Jun142021

We are proud to announce that we have successfully integrated 120 cases in the clinical study of Alexandria site.

Company News14/06/2021

We are proud to announce that we have successfully integrated 120 cases in the clinical study of Alexandria site. The initial trial launched in December 2019 at the Alexandria University, Egypt with Principal Investigators: Prof. Ahmed Elmassry and Prof. Osama Ibrahim and with the objective to perform the fixOflexTM implantation and 12-month follow up in 120 patients.

Details

May142021

Initiation of the additional clinical trial at the University of Crete

Company News14/05/2021

On the 14th of May 2021 we have successfully initiated the additional trial that was planned at the University of Crete in Greece in which Principal Investigator is Prof. Efstathios Detorakis. The intention being for launching this extra clinical trial is to elaborate more on the clinical findings in a small number of patients.

Feb282018

Establishment of EYE PCR

Company News28/02/2018

Today, Prof Ioannis Pallikaris announced the successful completion of the funding cycle permitted the